Oral anticoagulants for prevention of stroke in atrial fibrillation
Oral anticoagulants for prevention of stroke in atrial fibrillation
Cochrane Review
5 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Mouth dryness (at the end of treatment 4–6 weeks)
Placebo (sham acupuncture) |
-0.34 | - | - | Not assessed |
|
Unstimulated whole saliva (end of treatment)
Placebo (sham acupuncture) |
0.02 | - | - | Not assessed |
|
Stimulated whole saliva (end of treatment)
Placebo (sham acupuncture) |
0.19 | - | - | Not assessed |
|
Unstimulated whole saliva (1 year follow‐up)
Placebo (sham acupuncture) |
0.06 | - | - | Not assessed |
|
Stimulated whole saliva (1 year follow‐up)
Placebo (sham acupuncture) |
0.28 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD009603 |
| Outcomes: | 5 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
5